A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

ABSTRACT: The purpose of this study is to test the safety of GI-4000 and see what effects (good and bad) it has against cancer over time. This study is also being done to measure the immune response to GI-4000. Study drug will be given in addition to a standard of care which is a standard therapy given to patients with your type of cancer (colon).

DISEASE(S): Colon Cancer,Colonic Neoplasms

PROVIDER: 2104326 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR